Concurrent Interactive Sessions
Interactive and scientifically fun sessions in a mixture of lively formats such as debates, point-counterpoint discussions, brief talks with expert panel discussions, and “Rapid Fire” sessions: 4 or 5 short (5 mins) presentations by experts in the field.
HIV-1 and SARS-CoV-2: Durability of Host Immune Responses from Vaccination or Infection
- Waning Immunity in SARS-CoV-2 Infected Populations – Andrés Finzi, University of Montreal, Montreal, Canada
- T Cell Immunity in SARS-CoV-2 (Vaccines vs Infection) – Julie McElrath, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Population-Level Immunity – Katie Doores, King’s College London, London, United Kingdom
- Programming Durable Immunity – Robert Seder, Vaccine Research Center, Bethesda, MD USA
- Pathological B cell activation during SARS-CoV-2 Infection – Ignacio Sanz, Emory University, Atlanta, GA, USA
From Daily Pills to Monthly Shots for HIV Prevention and Treatment: Can Efficacy Be Translated into Effectiveness?
- Moderators
- Carlos del Rio, Emory University, Atlanta, GA, USA
- Diane Havlir, University of California San Francisco, San Francisco, CA, USA
- Panelists
- Francois Venter, Ezintsha School of Clinical Medicine, Johannesburg, South Africa
- Nittaya Phanuphak, Institute of HIV Research and Innovation, Bangkok, Thailand
- Charles Flexner, The Johns Hopkins University, Baltimore, MD, USA
- Hyman Scott, San Francisco Department of Public Health, San Francisco, CA. USA
PrEP Scale-Up to Meet UNAIDS 2030 Goals: Is it Possible?
- Moderator: Sheena McCormack, University College London, London, United Kingdom
- Panelists
- Elizabeth Irungu, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya
- Mark Dybul, Georgetown University, Washington, DC, USA